Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Reduction Of Chronic Post-surgical Pain with Ketamine - ROCKet Trial

To see complete record on, please visit this link

Id: ACTRN12617001619336

Organisation Name: The University of Melbourne

Overal Status: Recruiting

Start Date: 11/12/2017

Brief Summary: Chronic post-surgical pain (CPSP) is among the most common and debilitating complications of major surgery, with enormous long term costs to the economy and patients’ quality of life. Primary prevention is now seen as the “Holy Grail” of anaesthesiology. There is a well established physiological and pharmacological basis for the proposition that the widely used, potent analgesic ketamine given perioperatively reduces the development of CPSP in patients undergoing major surgery, and this is supported by meta-analysis of data from small placebo controlled published studies. The potential benefits in reducing the healthcare cost and the quality of life burden of chronic pain in the community are substantial. A large clinical trial of perioperative ketamine analgesia is urgently needed in patients undergoing general anaesthesia for major surgery. Proof of effectiveness would transform routine anaesthetic practice worldwide with huge economic and humanitarian benefits.

  • New Zealand
  • Hong Kong
  • Australia,Outside
  • Australia

Total execution time in seconds: 0.16220808029175